News Briefs

On March 9, global insurance brokerage firm Aon PLC agreed to buy fellow broker Willis Towers Watson in a deal that values the new firm at roughly $80 billion, according to a joint press release. The release emphasized the technology-driven nature of the deal and claimed the transaction will generate $10 billion in shareholder value. Companies like Aon and Willis Towers Watson help employers choose health plans and PBMs for their workers. Both firms’ stocks, which have trended downward since February, rallied the day after the announcement, but declined severely in subsequent days as markets crashed in response to an onslaught of bad COVID-19 news. Read the release at https://bit.ly/2QccPYS.

CMS on March 11 rolled out a voluntary model that would set out-of-pocket costs for insulin at a maximum $35 copayment per 30-day supply throughout the benefit year for beneficiaries in participating enhanced Part D plans. The goal is to ensure that beneficiaries in participating plans “will have predictable copays for a broad set of formulary insulins, including rapid-acting, short-acting, intermediate-acting, and long-acting insulins, marketed by participating manufacturers from the beginning of the plan year and through the coverage gap phase,” according to a press release. Visit https://go.cms.gov/39Kn1zx.

0 Comments
© 2023 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

capitol-hill
January 27

Even With Split Congress, Some Experts Predict Heightened Health Care Oversight

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
January 27

News Briefs: ACA Marketplace Enrollment Tops 16.3M

READ MORE
wall-street-logo
January 27

Elevance Sees Double-Digit Percentage EPS Growth for Fifth Consecutive Year

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today